DexCom (DXCM) PT Raised to $475 at UBS
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $91.25 +1.23%
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Join SI Premium – FREE
UBS analyst Matthew Taylor raised the price target on DexCom (NASDAQ: DXCM) to $475.00 (from $445.00) while maintaining a Buy rating.
You May Also Be Interested In
- Braze Inc (BRZE) PT Raised to $40 at DA Davidson
- GitLab Inc (GTLB) PT Raised to $52 at Piper Sandler
- MongoDB (MDB) PT Lowered to $450 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
